Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)

Clinical trial NCT01078220 · COMPLETED

Trial details

NCT number: NCT01078220
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Human Papillomavirus Infection

Start date: 2007-02-06
Primary completion: 2010-12-13
Enrollment: 189629

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.